History

Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation.  Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products.

Banner Image

Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation.  Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products.

Today Trinity Biotech is listed on the NASDAQ Global Select Market, and has approximately 21 million American Depository Shares. The Company, which has its headquarters in Bray, Ireland, employs in excess of 570 people worldwide and markets its portfolio of over 400 products to customers in over 110 countries around the world.

Image Image
1990
Mar 1994
Acquired Disease Detection International, Irvine, California, USA.
Jul 1996
Launched Uni-Gold™ HIV and One-step test.
Feb 1997
Acquired Clark Laboratories, Jamestown, New York, USA.
Jul 1997
Acquired Centocor, Cambridge, UK.
Mar 1998
Opened 50,000 sq. ft. manufacturing facility in Bray, Ireland.
Jun 1998
Acquired Hormone & Drugs of Abuse from Diatech, Boston, USA.
Jul 1998
Acquired Macra® Lp(a) from Strategic Diagnostics Inc., USA.
Sep 1998
Acquired HIV product line from Cambridge Diagnostics, USA.
Oct 1998
Acquired MicroTrak® product line from Dade Behring, USA.
2000
Mar 2000
Acquired MarDx® Diagnostics, Inc., Carlsbad, California, USA. Dec-Acquired assets and goodwill of Bartels Inc., Oregon, USA.
Dec 2000
Acquired assets and goodwill of Bartels Inc., Oregon, USA.
Oct 2001
Establishment of Trinity Biotech German sales and marketing subsidiary
Dec 2001
Acquired Biopool, Ventura, California, USA.
Aug 2002
Acquired coagulation division of Sigma Diagnostics, USA. Oct-Establishment of Trinity Biotech UK sales & marketing subsidiary. Dec-Acquired Specialty Clinical Chemistry, Sigma Diagnostics, USA.
Oct 2002
Establishment of Trinity Biotech UK sales & marketing subsidiary.
Dec 2002
Acquired Specialty Clinical Chemistry, Sigma Diagnostics, USA.
Dec 2003
FDA clearance for Uni-Gold™ Recombigen® HIV test.
Apr 2004
Acquired Adaltis US, Inc. Apr-Acquires Fitzgerald Industries International, Mass, USA.
Nov 2004
Received US CLIA Waiver for Uni-Gold™ Recombigen® HIV Test.
Mar 2005
Mar-Acquired Research Diagnostics Inc., Flanders, New Jersey, USA.
Jul 2005
Acquired Primus Corporation of Kansas City, Missouri, USA.
Jun 2006
Acquired coagulation division of bioMerieux, Lyon, France.
2010
May 2010
Acquisition by Stago of the Trinity Biotech coagulation division.
Jan 2011
Acquired Phoenix Bio-tech Corporation May-Launch of Premier Hb9210
Mar 2012
Mar-Acquisition of Fiomi Diagnostics AB
Jul 2013
Acquisition of Immco Diagnostics Inc., Buffalo, NY, USA Jul-Acquisition of the blood bank screening business of Lab21 ltd.
2020
May 2024
Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
Sep 2024
Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
Sep 2024
Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
Oct 2024
Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture
Oct 2024
Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024